14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.87 $1.65 Thursday, 25th Apr 2024 ADAP stock ended at $1.06. This is 1.85% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 5.69% from a day low at $1.04 to a day high of $1.10.
90 days $0.720 $2.05
52 weeks $0.420 $2.05

Historical Adaptimmune Therapeutics plc prices

Date Open High Low Close Volume
Jun 02, 2022 $1.43 $1.48 $1.42 $1.42 118 866
Jun 01, 2022 $1.44 $1.49 $1.41 $1.45 215 003
May 31, 2022 $1.51 $1.55 $1.43 $1.44 267 008
May 27, 2022 $1.50 $1.54 $1.40 $1.52 252 032
May 26, 2022 $1.45 $1.49 $1.43 $1.46 225 231
May 25, 2022 $1.54 $1.57 $1.42 $1.48 215 026
May 24, 2022 $1.53 $1.53 $1.43 $1.47 255 162
May 23, 2022 $1.64 $1.65 $1.50 $1.51 308 149
May 20, 2022 $1.73 $1.76 $1.55 $1.64 263 166
May 19, 2022 $1.45 $1.79 $1.43 $1.67 785 467
May 18, 2022 $1.56 $1.56 $1.46 $1.47 121 804
May 17, 2022 $1.52 $1.61 $1.46 $1.57 377 187
May 16, 2022 $1.40 $1.48 $1.37 $1.42 211 540
May 13, 2022 $1.37 $1.46 $1.35 $1.41 272 511
May 12, 2022 $1.33 $1.43 $1.26 $1.35 718 533
May 11, 2022 $1.53 $1.54 $1.33 $1.33 623 387
May 10, 2022 $1.56 $1.64 $1.48 $1.56 556 378
May 09, 2022 $1.75 $1.97 $1.50 $1.54 830 713
May 06, 2022 $1.75 $1.78 $1.65 $1.71 1 116 541
May 05, 2022 $1.90 $1.91 $1.77 $1.78 192 517
May 04, 2022 $1.85 $1.92 $1.76 $1.91 370 970
May 03, 2022 $1.90 $1.91 $1.81 $1.82 223 358
May 02, 2022 $1.70 $1.87 $1.70 $1.87 361 217
Apr 29, 2022 $1.74 $1.83 $1.71 $1.72 297 815
Apr 28, 2022 $1.75 $1.77 $1.65 $1.75 5 514 648
Click to get the best stock tips daily for free!

About Adaptimmune Therapeutics plc

Adaptimmune Therapeutics plc Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4 that is in phase II clinical trials with SPEARHEAD-1 for synovial sarcoma and myxoid round cell liposa... ADAP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT